TRANSITION SERVICES CONSULTING AGREEMENTConsulting Agreement • May 10th, 2021 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2021 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), dated as of December 31, 2018 with an effective date of February 1, 2019 (the “Effective Date”), is entered into by and between Alzamend Neuro, a Delaware corporation, having his headquarters 3802 Spectrum Boulevard, Suite 112C, Tampa, Florida 33612 and William B. Horne, an individual (the “Consultant”). This Agreement supersedes any prior oral or written agreements between the parties hereto related to the matters set forth herein.
TRANSITION SERVICES CONSULTING AGREEMENTConsulting Agreement • April 2nd, 2021 • Alzamend Neuro, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 2nd, 2021 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), dated as of December 31, 2018 with an effective date of February 1, 2019 (the “Effective Date”), is entered into by and between Alzamend Neuro, a Delaware corporation, having his headquarters 3802 Spectrum Boulevard, Suite 112C, Tampa, Florida 33612 and William B. Horne, an individual (the “Consultant”). This Agreement supersedes any prior oral or written agreements between the parties hereto related to the matters set forth herein.